Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PSMD3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | CCER2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | LEPROTL1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | NIPA2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | CBSL | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | DYTN | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | C20orf96 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | CDH24 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | PLXNB1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | LPAR2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |